bcrmut | 20821
TKI resistance BCR-ABL
Keywords:
MPN
imatinib resistance CML
myeloproliferative neoplasms
Status
| Material |
|
||
|---|---|---|---|
| Hint |
There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order.
|
||
| Min. volume | 4 mL | ||
| Stability |
Stability
1 day / 2-8°C
|
||
| Duration | 3 days | ||
| Frequency | 2 x per week |
Price/Rate
| Price |
Price
CHF 0.00
|
|---|---|
| Rate |
Rate
0.00 TP
|
Executing laboratory
| External laboratory |
|---|